acyclovir - Generic mfg.
Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe
Prevymis (letermovir) - Merck (MSD)
Letermovir for CMV Prevention After Lung Transplantation (clinicaltrials.gov) - Jul 8, 2025 - P2 | N=16 | Completed | Sponsor: Fernanda P Silveira, MD, MS | Active, not recruiting ➔ Completed | Trial completion date: Jul 2025 ➔ Mar 2025 | Trial primary completion date: Jul 2025 ➔ Mar 2025 
Trial completion • Trial completion date • Trial primary completion date • Cytomegalovirus Infection • Idiopathic Pulmonary Fibrosis • Immunology • Infectious Disease • Neutropenia • Pulmonary Disease • Respiratory Diseases • Transplantation
http://clinicaltrials.gov/ct2/show/NCT05041426
 
Jul 8, 2025
 
Prev Next